Literature DB >> 1586610

Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis.

D J Cole1, D C Brown, E Crossley, C J Alcock, K C Gatter.   

Abstract

The aim of this study was to ascertain whether assessing the growth fraction of cervical carcinoma of 28 patients, using antibody Ki-67, would be of value in clinical practice. The results showed no relationship between growth fraction and age, clinical stage, lymph node involvement or short term (3-5 years) survival.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1586610      PMCID： PMC1977376          DOI： 10.1038/bjc.1992.167

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  21 in total

Review 1.  Monoclonal antibody Ki-67: its use in histopathology.

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

2.  Low molecular weight cytokeratin proteins in cervical neoplasia.

Authors:  M Wells; L J Brown; P Jackson
Journal:  J Pathol       Date:  1986-09       Impact factor: 7.996

3.  The value of immunohistochemical markers in the diagnosis of cervical neoplasia.

Authors:  R E Fray; O A Husain; A C To; K C Watts; S Lader; G T Rogers; J Taylor-Papadimitriou; N F Morris
Journal:  Br J Obstet Gynaecol       Date:  1984-10

4.  Cervical carcinoma: prognosis in younger patients.

Authors:  J M Russell; V Blair; R D Hunter
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

5.  Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

Authors:  J Gerdes; R J Lelle; H Pickartz; W Heidenreich; R Schwarting; L Kurtsiefer; G Stauch; H Stein
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

6.  New approach to assessing lung tumours in man.

Authors:  K C Gatter; M S Dunnill; J Gerdes; H Stein; D Y Mason
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

7.  Expression of low molecular weight cytokeratin proteins in cervical neoplasia.

Authors:  L G Bobrow; C A Makin; S Law; W F Bodmer
Journal:  J Pathol       Date:  1986-02       Impact factor: 7.996

8.  The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma.

Authors:  P A Hall; M A Richards; W M Gregory; A J d'Ardenne; T A Lister; A G Stansfeld
Journal:  J Pathol       Date:  1988-03       Impact factor: 7.996

9.  Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67.

Authors:  D C Brown; D Cole; K C Gatter; D Y Mason
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

10.  Histological cell type and DNA value in the prognosis of squamous cell cancer of uterine cervix.

Authors:  A B Ng; N B Atkin
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640
View more
  8 in total

1.  Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?

Authors:  S Sahebali; C E Depuydt; K Segers; A J Vereecken; E Van Marck; J J Bogers
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

2.  Hypoxia markers in human osteosarcoma: an exploratory study.

Authors:  Hiroo Mizobuchi; José Manuel García-Castellano; Shaji Philip; John H Healey; Richard Gorlick
Journal:  Clin Orthop Relat Res       Date:  2008-06-05       Impact factor: 4.176

3.  Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.

Authors:  A S Allal; L Alonso-Pentzke; S Remadi
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

4.  Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.

Authors:  B S Bolger; R P Symonds; P D Stanton; A B MacLean; R Burnett; P Kelly; T G Cooke
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

Review 5.  The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis.

Authors:  Denghua Pan; Kanglai Wei; Yanxin Ling; Shitao Su; Meilin Zhu; Gang Chen
Journal:  Med Sci Monit       Date:  2015-03-25

6.  Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.

Authors:  Yada Kanjanapan; Siddhartha Deb; Richard J Young; Mathias Bressel; Linda Mileshkin; Danny Rischin; Michael S Hofman; Kailash Narayan; Shankar Siva
Journal:  Clin Transl Radiat Oncol       Date:  2017-02-08

7.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07

8.  Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.

Authors:  B S Bolger; T G Cooke; R P Symonds; A B MacLean; P D Stanton
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.